Published in PLoS Negl Trop Dis on January 27, 2009
Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol (2011) 2.20
The Influence of Socio-economic, Behavioural and Environmental Factors on Taenia spp. Transmission in Western Kenya: Evidence from a Cross-Sectional Survey in Humans and Pigs. PLoS Negl Trop Dis (2015) 1.46
Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis (2011) 1.31
Use of statewide hospital discharge data to evaluate the economic burden of neurocysticercosis in Los Angeles County (1991-2008). Am J Trop Med Hyg (2010) 1.15
Diagnosis and treatment of neurocysticercosis. Interdiscip Perspect Infect Dis (2009) 1.15
Update on Cysticercosis Epileptogenesis: the Role of the Hippocampus. Curr Neurol Neurosci Rep (2016) 1.15
Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Pathog Glob Health (2012) 1.06
Taenia solium Human Cysticercosis: A Systematic Review of Sero-epidemiological Data from Endemic Zones around the World. PLoS Negl Trop Dis (2015) 1.00
Neurocysticercosis in the United States. Pathog Glob Health (2012) 0.98
Relationship between serum antibodies and Taenia solium larvae burden in pigs raised in field conditions. PLoS Negl Trop Dis (2013) 0.98
High prevalence of cysticercosis in people with epilepsy in southern Rwanda. PLoS Negl Trop Dis (2013) 0.97
Detection of Taenia solium taeniasis coproantigen is an early indicator of treatment failure for taeniasis. Clin Vaccine Immunol (2012) 0.93
Prevention and control of Taenia solium taeniasis/cysticercosis in Peru. Pathog Glob Health (2012) 0.89
Neurocysticercosis. Neurohospitalist (2014) 0.86
Porcine cysticercosis in southeast Uganda: seroprevalence in kamuli and kaliro districts. J Parasitol Res (2009) 0.86
A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches. PLoS Negl Trop Dis (2011) 0.85
Cysticercosis control: bringing advances to the field. J Glob Infect Dis (2011) 0.83
Analyses of an expressed sequence tag library from Taenia solium, Cysticerca. PLoS Negl Trop Dis (2010) 0.83
New insights in cysticercosis transmission. PLoS Negl Trop Dis (2014) 0.80
Prevalence of and Factors Associated with Human Cysticercosis in 60 Villages in Three Provinces of Burkina Faso. PLoS Negl Trop Dis (2015) 0.79
Taenia solium infection in Peru: a collaboration between Peace Corps Volunteers and researchers in a community based study. PLoS One (2014) 0.78
Study and ranking of determinants of Taenia solium infections by classification tree models. Am J Trop Med Hyg (2014) 0.78
Evaluation of an immunodot blot technique for the detection of antibodies against Taenia solium larval antigens. Parasitol Res (2012) 0.77
Distribution and Potential Indicators of Hospitalized Cases of Neurocysticercosis and Epilepsy in Ecuador from 1996 to 2008. PLoS Negl Trop Dis (2015) 0.76
Modelling the risk of Taenia solium exposure from pork produced in western Kenya. PLoS Negl Trop Dis (2017) 0.75
Human cysticercosis (Taenia solium). Trop Parasitol (2013) 0.75
Commentary. J Neurosci Rural Pract (2014) 0.75
Taenia solium Taeniasis and Cysticercosis in Southeast Asia. Am J Trop Med Hyg (2016) 0.75
Report of three imported cases of neurocysticercosis in Guadeloupe. BMC Infect Dis (2017) 0.75
Spatial relationship between Taenia solium tapeworm carriers and necropsy cyst burden in pigs. PLoS Negl Trop Dis (2017) 0.75
The causal relationship between neurocysticercosis infection and the development of epilepsy - a systematic review. Infect Dis Poverty (2017) 0.75
Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia (1989) 13.54
Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia (1981) 9.42
Taenia solium cysticercosis. Lancet (2003) 5.89
Neurocysticercosis: updated concepts about an old disease. Lancet Neurol (2005) 5.37
An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis (1989) 5.21
An ether sedimentation technique for routine stool examinations. Bull U S Army Med Dep (1948) 2.21
Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology (2005) 2.04
Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis (1991) 1.95
Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain (1992) 1.94
Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am J Trop Med Hyg (2007) 1.54
Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence. Am J Trop Med Hyg (2001) 1.52
Taenia solium taeniasis and cysticercosis in a Mexican village. Trop Med Parasitol (1988) 1.46
Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú. Neurology (1999) 1.42
A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41
Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis (1994) 1.22
Field trial of the coproantigen-based diagnosis of Taenia solium taeniasis by enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1996) 1.20
Epidemiology of taeniasis and cysticercosis in a Peruvian village. The Cysticercosis Working Group in Peru. Am J Epidemiol (1992) 1.15
Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. TheCysticercosis Working Group in Perú. Neurology (2000) 1.12
Hydatidosis and cysticercosis: the dynamics of transmission. Adv Parasitol (1983) 1.09
Application of the enzyme-linked immunoelectrotransfer blot to filter paper blood spots to estimate seroprevalence of cysticercosis in Bolivia. Am J Trop Med Hyg (1998) 1.02
A large-scale study of epilepsy in Ecuador: methodological aspects. Neuroepidemiology (1992) 0.99
Economic burden of neurocysticercosis: results from Peru. Trans R Soc Trop Med Hyg (2007) 0.98
Neurocysticercosis: validity of ELISA after storage of whole blood and cerebrospinal fluid on paper. Trop Med Int Health (2001) 0.96
Seroincidence of porcine T. solium infection in the Peruvian highlands. Prev Vet Med (2003) 0.91
The Styx Field Trial: effect of treatment of the definitive host for tapeworms on larval forms in the intermediate host. Bull World Health Organ (1978) 0.86
Serology as an indicator of Taenia solium tapeworm infections in a rural community in Mexico. Trans R Soc Trop Med Hyg (1991) 0.83
Taeniasis and cysticercosis in housemaids working in affluent neighborhoods in Lima, Peru. Am J Trop Med Hyg (2005) 0.83
Detection of anti-cysticercus antibodies by ELISA using whole blood collected on filter paper. Trans R Soc Trop Med Hyg (2001) 0.80
Risk of seizures and neurocysticercosis in household family contacts of children with single enhancing lesions. J Neurol Sci (2000) 0.79
Factors regulating tapeworm populations: dispersion of eggs of Taenia hydatigena on pasture. Ann Trop Med Parasitol (1976) 0.79
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis (2003) 15.02
Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med (2006) 8.39
Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med (2009) 8.26
Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet (2009) 6.80
Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS (2005) 6.10
Taenia solium cysticercosis. Lancet (2003) 5.89
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75
Neurocysticercosis: updated concepts about an old disease. Lancet Neurol (2005) 5.37
Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA (2007) 5.22
Human brucellosis. Lancet Infect Dis (2007) 4.92
Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet (2002) 4.90
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis (2014) 4.64
Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol (2008) 4.46
Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community. Lancet (2004) 4.36
Effect of the Integrated Management of Childhood Illness strategy on childhood mortality and nutrition in a rural area in Bangladesh: a cluster randomised trial. Lancet (2009) 4.11
The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS (2007) 4.09
Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. J Acquir Immune Defic Syndr (2004) 3.86
Natural ventilation for the prevention of airborne contagion. PLoS Med (2007) 3.73
The effect of deforestation on the human-biting rate of Anopheles darlingi, the primary vector of Falciparum malaria in the Peruvian Amazon. Am J Trop Med Hyg (2006) 3.72
Prevention and control of cystic echinococcosis. Lancet Infect Dis (2007) 3.64
Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet (2005) 3.60
Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis (2006) 3.54
New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med (2011) 3.46
Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J (2007) 3.40
Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37
Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS (2008) 3.32
Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol (2004) 3.27
Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04
Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis (2013) 2.95
Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis (2006) 2.83
The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS Med (2008) 2.79
Update on the human broad tapeworm (genus diphyllobothrium), including clinical relevance. Clin Microbiol Rev (2009) 2.78
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY). J Acquir Immune Defic Syndr (2011) 2.75
Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda. J Infect Dis (2010) 2.70
Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis (2010) 2.69
Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Arch Pediatr Adolesc Med (2005) 2.68
Linking deforestation to malaria in the Amazon: characterization of the breeding habitat of the principal malaria vector, Anopheles darlingi. Am J Trop Med Hyg (2009) 2.64
Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet (2003) 2.49
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46
Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg (2003) 2.43
Species identification after treatment for human taeniasis. Lancet (2004) 2.43
Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol (2011) 2.41
Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis (2013) 2.37
The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis (2007) 2.28
Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe. Am J Clin Nutr (2005) 2.27
Nonmedical exemptions to school immunization requirements: secular trends and association of state policies with pertussis incidence. JAMA (2006) 2.25
Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. JAMA (2004) 2.25
Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol (2011) 2.20
Pulmonary cystic echinococcosis. Curr Opin Pulm Med (2010) 2.20
Elimination of Taenia solium Transmission in Northern Peru. N Engl J Med (2016) 2.15
Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis (2010) 2.11
Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11
Geographic clustering of nonmedical exemptions to school immunization requirements and associations with geographic clustering of pertussis. Am J Epidemiol (2008) 2.10
Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr (2010) 2.10
New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg (2005) 2.10
The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med (2008) 2.08
Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06
Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg (2006) 2.05
Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ (2010) 2.05
Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology (2005) 2.04
Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease. Clin Infect Dis (2010) 2.03
Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries? Trans R Soc Trop Med Hyg (2008) 2.01
Environmental exposure and leptospirosis, Peru. Emerg Infect Dis (2004) 1.96
Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis (2008) 1.96
Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe (2009) 1.96
Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda. J Infect Dis (2010) 1.92
Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med (2006) 1.92
Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidemiol (2003) 1.90
Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2008) 1.87
Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J (2011) 1.86
Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis (2006) 1.85
Epilepsy in poor regions of the world. Lancet (2012) 1.85
Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis (2009) 1.81
The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS (2006) 1.79